Menten AI Company
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Investors
Technology:
Artificial Intelligence, Biotechnology, Chemical, Health Care, Life Science, Machine Learning, Pharmaceutical, Quantum Computing, Therapeutics
Industry:
AI, Early Drug Development, United States
Headquarters:
Palo Alto, California, United States
Founded Date:
2018-08-24
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
6
Total Funding:
4005000
Last Funding Date:
2020-06-30
Last Funding Type:
Seed
Register and Claim Ownership